[Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].
作者信息
Saku Keijiro, Zhang Bo, Noda Keita
机构信息
Department of Cardiology, Fukuoka University School of Medicine, Japan.
出版信息
Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3679-86. doi: 10.2169/naika.100.3679.
PMID:22338904
Abstract
摘要
相似文献
1
[Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial].
Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3679-86. doi: 10.2169/naika.100.3679.
2
Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.
Circ J. 2011;75(6):1493-505. doi: 10.1253/circj.cj-10-1281. Epub 2011 Apr 15.
3
Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not?
Circ J. 2011;75(6):1326-7. doi: 10.1253/circj.cj-11-0410. Epub 2011 Apr 29.
4
Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Clin Ther. 2004 Nov;26(11):1821-33. doi: 10.1016/j.clinthera.2004.11.015.
5
Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).
Am J Cardiol. 2007 Jun 1;99(11):1538-43. doi: 10.1016/j.amjcard.2007.01.028. Epub 2007 Apr 16.
6
Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.
Am J Cardiol. 2008 Dec 15;102(12):1654-62. doi: 10.1016/j.amjcard.2008.08.014. Epub 2008 Sep 20.
7
Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
Am Heart J. 2004 Jul;148(1):e4. doi: 10.1016/j.ahj.2004.01.020.
8
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
Am J Cardiol. 2003 Jul 15;92(2):152-60. doi: 10.1016/s0002-9149(03)00530-7.
9
More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy.
Circ J. 2004 Feb;68(2):107-13. doi: 10.1253/circj.68.107.
10
Is rosuvastatin really a more efficient therapeutic option than atorvastatin?
Value Health. 2006 Jul-Aug;9(4):276-7; author reply 277-9. doi: 10.1111/j.1524-4733.2006.00111.x.
引用本文的文献
1
Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials.
Cardiovasc Ther. 2020 Apr 23;2020:3987065. doi: 10.1155/2020/3987065. eCollection 2020.
Zotero 插件